-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Maintains Neutral on Macrogenics, Lowers Price Target to $3

Benzinga·05/20/2025 14:52:57
Listen to the news
B. Riley Securities analyst Mayank Mamtani maintains Macrogenics (NASDAQ:MGNX) with a Neutral and lowers the price target from $5 to $3.